Global mRNA Raw Enzyme Market Growth (Status and Outlook) 2025-2031

Publication ID:

LPI04254153

Publication Date:

April 22, 2025

Pages:

120

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global mRNA Raw Enzyme market size is predicted to grow from US$ 1576 million in 2025 to US$ 1721 million in 2031; it is expected to grow at a CAGR of 1.5% from 2025 to 2031.
mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials. In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2"-O-Methyltransferase, Poly(A) Polymerase and DNase I.
Global key players of mRNA Raw Enzyme include Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, etc. The top five players hold a share about 62%. North America is the largest market, and has a share about 41%, followed by Europe and Asia-Pacific with share 34% and 21%, separately. In terms of product type, Capping Enzyme is the largest segment, accounting for a share of 26%. In terms of application, Biopharmaceutical Companies is the largest field with a share about 63 percent.
The 鈥渕RNA Raw Enzyme Industry Forecast鈥� looks at past sales and reviews total world mRNA Raw Enzyme sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Raw Enzyme sales for 2025 through 2031. With mRNA Raw Enzyme sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Raw Enzyme industry.
This Insight Report provides a comprehensive analysis of the global mRNA Raw Enzyme landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Raw Enzyme portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global mRNA Raw Enzyme market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Raw Enzyme and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Raw Enzyme.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Raw Enzyme market by product type, application, key players and key regions and countries.
Segmentation by Type:
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Segmentation by Application:
Biopharmaceutical Companies
Academic and Research Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology (Shanghai)
Kactus Biosystems

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global mRNA Raw Enzyme Market Size (2020-2031)
2.1.2 mRNA Raw Enzyme Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for mRNA Raw Enzyme by Country/Region (2020, 2024 & 2031)
2.2 mRNA Raw Enzyme Segment by Type
2.2.1 Capping Enzyme
2.2.2 2'-O-Methyltransferase
2.2.3 Inorganic Pyrophosphatase
2.2.4 Poly (A) Polymerase
2.2.5 Rnase Inhibitor
2.2.6 RNA Polymerase
2.2.7 Restriction Enzyme
2.2.8 Dnase I
2.2.9 Others
2.3 mRNA Raw Enzyme Market Size by Type
2.3.1 mRNA Raw Enzyme Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global mRNA Raw Enzyme Market Size Market Share by Type (2020-2025)
2.4 mRNA Raw Enzyme Segment by Application
2.4.1 Biopharmaceutical Companies
2.4.2 Academic and Research Institutes
2.5 mRNA Raw Enzyme Market Size by Application
2.5.1 mRNA Raw Enzyme Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global mRNA Raw Enzyme Market Size Market Share by Application (2020-2025)
3 mRNA Raw Enzyme Market Size by Player
3.1 mRNA Raw Enzyme Market Size Market Share by Player
3.1.1 Global mRNA Raw Enzyme Revenue by Player (2020-2025)
3.1.2 Global mRNA Raw Enzyme Revenue Market Share by Player (2020-2025)
3.2 Global mRNA Raw Enzyme Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Raw Enzyme by Region
4.1 mRNA Raw Enzyme Market Size by Region (2020-2025)
4.2 Global mRNA Raw Enzyme Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Raw Enzyme Market Size Growth (2020-2025)
4.4 APAC mRNA Raw Enzyme Market Size Growth (2020-2025)
4.5 Europe mRNA Raw Enzyme Market Size Growth (2020-2025)
4.6 Middle East & Africa mRNA Raw Enzyme Market Size Growth (2020-2025)
5 Americas
5.1 Americas mRNA Raw Enzyme Market Size by Country (2020-2025)
5.2 Americas mRNA Raw Enzyme Market Size by Type (2020-2025)
5.3 Americas mRNA Raw Enzyme Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Raw Enzyme Market Size by Region (2020-2025)
6.2 APAC mRNA Raw Enzyme Market Size by Type (2020-2025)
6.3 APAC mRNA Raw Enzyme Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Raw Enzyme Market Size by Country (2020-2025)
7.2 Europe mRNA Raw Enzyme Market Size by Type (2020-2025)
7.3 Europe mRNA Raw Enzyme Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Raw Enzyme by Region (2020-2025)
8.2 Middle East & Africa mRNA Raw Enzyme Market Size by Type (2020-2025)
8.3 Middle East & Africa mRNA Raw Enzyme Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global mRNA Raw Enzyme Market Forecast
10.1 Global mRNA Raw Enzyme Forecast by Region (2026-2031)
10.1.1 Global mRNA Raw Enzyme Forecast by Region (2026-2031)
10.1.2 Americas mRNA Raw Enzyme Forecast
10.1.3 APAC mRNA Raw Enzyme Forecast
10.1.4 Europe mRNA Raw Enzyme Forecast
10.1.5 Middle East & Africa mRNA Raw Enzyme Forecast
10.2 Americas mRNA Raw Enzyme Forecast by Country (2026-2031)
10.2.1 United States Market mRNA Raw Enzyme Forecast
10.2.2 Canada Market mRNA Raw Enzyme Forecast
10.2.3 Mexico Market mRNA Raw Enzyme Forecast
10.2.4 Brazil Market mRNA Raw Enzyme Forecast
10.3 APAC mRNA Raw Enzyme Forecast by Region (2026-2031)
10.3.1 China mRNA Raw Enzyme Market Forecast
10.3.2 Japan Market mRNA Raw Enzyme Forecast
10.3.3 Korea Market mRNA Raw Enzyme Forecast
10.3.4 Southeast Asia Market mRNA Raw Enzyme Forecast
10.3.5 India Market mRNA Raw Enzyme Forecast
10.3.6 Australia Market mRNA Raw Enzyme Forecast
10.4 Europe mRNA Raw Enzyme Forecast by Country (2026-2031)
10.4.1 Germany Market mRNA Raw Enzyme Forecast
10.4.2 France Market mRNA Raw Enzyme Forecast
10.4.3 UK Market mRNA Raw Enzyme Forecast
10.4.4 Italy Market mRNA Raw Enzyme Forecast
10.4.5 Russia Market mRNA Raw Enzyme Forecast
10.5 Middle East & Africa mRNA Raw Enzyme Forecast by Region (2026-2031)
10.5.1 Egypt Market mRNA Raw Enzyme Forecast
10.5.2 South Africa Market mRNA Raw Enzyme Forecast
10.5.3 Israel Market mRNA Raw Enzyme Forecast
10.5.4 Turkey Market mRNA Raw Enzyme Forecast
10.6 Global mRNA Raw Enzyme Forecast by Type (2026-2031)
10.7 Global mRNA Raw Enzyme Forecast by Application (2026-2031)
10.7.1 GCC Countries Market mRNA Raw Enzyme Forecast
11 Key Players Analysis
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Information
11.1.2 Thermo Fisher mRNA Raw Enzyme Product Offered
11.1.3 Thermo Fisher mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Thermo Fisher Main Business Overview
11.1.5 Thermo Fisher Latest Developments
11.2 NEB
11.2.1 NEB Company Information
11.2.2 NEB mRNA Raw Enzyme Product Offered
11.2.3 NEB mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 NEB Main Business Overview
11.2.5 NEB Latest Developments
11.3 TriLink Bio Technologies
11.3.1 TriLink Bio Technologies Company Information
11.3.2 TriLink Bio Technologies mRNA Raw Enzyme Product Offered
11.3.3 TriLink Bio Technologies mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 TriLink Bio Technologies Main Business Overview
11.3.5 TriLink Bio Technologies Latest Developments
11.4 Merck
11.4.1 Merck Company Information
11.4.2 Merck mRNA Raw Enzyme Product Offered
11.4.3 Merck mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Merck Main Business Overview
11.4.5 Merck Latest Developments
11.5 Aldevron
11.5.1 Aldevron Company Information
11.5.2 Aldevron mRNA Raw Enzyme Product Offered
11.5.3 Aldevron mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Aldevron Main Business Overview
11.5.5 Aldevron Latest Developments
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Information
11.6.2 Qiagen N.V. mRNA Raw Enzyme Product Offered
11.6.3 Qiagen N.V. mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Qiagen N.V. Main Business Overview
11.6.5 Qiagen N.V. Latest Developments
11.7 Promega
11.7.1 Promega Company Information
11.7.2 Promega mRNA Raw Enzyme Product Offered
11.7.3 Promega mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Promega Main Business Overview
11.7.5 Promega Latest Developments
11.8 Roche CustomBiotech
11.8.1 Roche CustomBiotech Company Information
11.8.2 Roche CustomBiotech mRNA Raw Enzyme Product Offered
11.8.3 Roche CustomBiotech mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Roche CustomBiotech Main Business Overview
11.8.5 Roche CustomBiotech Latest Developments
11.9 Takara Bio Inc
11.9.1 Takara Bio Inc Company Information
11.9.2 Takara Bio Inc mRNA Raw Enzyme Product Offered
11.9.3 Takara Bio Inc mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Takara Bio Inc Main Business Overview
11.9.5 Takara Bio Inc Latest Developments
11.10 Novoprotein
11.10.1 Novoprotein Company Information
11.10.2 Novoprotein mRNA Raw Enzyme Product Offered
11.10.3 Novoprotein mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Novoprotein Main Business Overview
11.10.5 Novoprotein Latest Developments
11.11 Vazyme
11.11.1 Vazyme Company Information
11.11.2 Vazyme mRNA Raw Enzyme Product Offered
11.11.3 Vazyme mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 Vazyme Main Business Overview
11.11.5 Vazyme Latest Developments
11.12 Hongene Biotech Corporatio
11.12.1 Hongene Biotech Corporatio Company Information
11.12.2 Hongene Biotech Corporatio mRNA Raw Enzyme Product Offered
11.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Hongene Biotech Corporatio Main Business Overview
11.12.5 Hongene Biotech Corporatio Latest Developments
11.13 Yeasen Biotechnology (Shanghai)
11.13.1 Yeasen Biotechnology (Shanghai) Company Information
11.13.2 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Product Offered
11.13.3 Yeasen Biotechnology (Shanghai) mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 Yeasen Biotechnology (Shanghai) Main Business Overview
11.13.5 Yeasen Biotechnology (Shanghai) Latest Developments
11.14 Kactus Biosystems
11.14.1 Kactus Biosystems Company Information
11.14.2 Kactus Biosystems mRNA Raw Enzyme Product Offered
11.14.3 Kactus Biosystems mRNA Raw Enzyme Revenue, Gross Margin and Market Share (2020-2025)
11.14.4 Kactus Biosystems Main Business Overview
11.14.5 Kactus Biosystems Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂